Histone Deacetylase Inhibitors [MoA] - N0000175071

Pharmacologic Code	N0000175071
Pharmacologic Name	Histone Deacetylase Inhibitors
Pharmacologic Uses	histone deacetylase (HDAC) inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Histone Deacetylase Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0006-0568	Zolinza	Non-Proprietary Name: Vorinostat	Capsule	Oral	Merck Sharp & Dohme Llc	ACTIVE
	0703-4004	Romidepsin	Non-Proprietary Name: Romidepsin	Injection, Solution, Concentrate	Intravenous	Teva Parenteral Medicines, Inc.	ACTIVE
	72893-002	Beleodaq	Non-Proprietary Name: Belinostat	Injection, Powder, Lyophilized, For Solution	Intravenous	Acrotech Biopharma Inc	ACTIVE